ZITEVARD Trademark

Trademark Overview

On Wednesday, December 21, 2011, a trademark application was filed for ZITEVARD with the United States Patent and Trademark Office. The USPTO has given the ZITEVARD trademark a serial number of 85501301. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 11, 2014. This trademark is owned by AstraZeneca AB. The ZITEVARD trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances in the fields of oncology, cardiovascular diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, nervous system diseases and disorders, and not including calcium channel blockers
zitevard

General Information

Serial Number85501301
Word MarkZITEVARD
Filing DateWednesday, December 21, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 11, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2013

Trademark Statements

Goods and Servicespharmaceutical preparations and substances in the fields of oncology, cardiovascular diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, nervous system diseases and disorders, and not including calcium channel blockers
Translation of Words in MarkThe word(s) "ZITEVARD" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 4, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-151 85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-151 85
SE

Trademark Events

Event DateEvent Description
Monday, August 11, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 11, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 7, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 9, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, October 9, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 9, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, October 9, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, April 15, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 15, 2013INQUIRY TO SUSPENSION E-MAILED
Monday, April 15, 2013SUSPENSION INQUIRY WRITTEN
Monday, April 15, 2013LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, October 15, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 15, 2012LETTER OF SUSPENSION E-MAILED
Monday, October 15, 2012SUSPENSION LETTER WRITTEN
Monday, October 15, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 15, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2012ASSIGNED TO LIE
Tuesday, October 2, 2012ASSIGNED TO LIE
Monday, September 24, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 9, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 9, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 29, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 29, 2012NON-FINAL ACTION E-MAILED
Thursday, March 29, 2012NON-FINAL ACTION WRITTEN
Tuesday, March 27, 2012ASSIGNED TO EXAMINER
Wednesday, January 4, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

zitevard diseases disorders nervous gastrointestinal system including blockers channel calcium infection